Experts engage in discussion on patient profiles to review updated treatment approaches and sequencing in patients with HER2-positive metastatic breast cancer.
June 22nd 2022
A brief discussion on optimally managing adverse events while treating patients with HER2+ breast cancer.
Experts consider how best to manage adverse events associated with the HER2CLIMB regimen in the setting of HER2+ metastatic breast cancer.
June 29th 2022
Before closing out the discussion on the management of HER2+ breast cancer, experts share their excitement on future treatment strategies.